- Investor's Business Daily•14 hours ago
Barclays analyst Geoff Meacham on Thursday said he expected Gilead Sciences' 2017 outlook to be hindered on limited hepatitis C sales.
- Market Realist•14 hours ago
Johnson & Johnson is set to release its 4Q16 earnings on January 24, 2017.
- Investopedia•15 hours ago
Will a lower corporate tax rate help bring more profit to the industry? They may already be doing it on their own.
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||113.92 - 114.90|
|52 Week Range||95.95 - 126.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.05|
|Dividend & Yield||3.20 (2.79%)|
|1y Target Est||N/A|